CNBX PHARMACEUTICALS INC. Available-for-sale Securities, Gross Realized Gain (Loss)
CNBX PHARMACEUTICALS INC. (CNBX) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $0 for the 3-month period ending 2021-05-31, per its 10-Q filed 2021-07-14.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2021-07-14
- CNBX PHARMACEUTICALS INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2021-05-31 was $0.00.
- CNBX PHARMACEUTICALS INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2021-02-28 was $195.97K.
- CNBX PHARMACEUTICALS INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2020-05-31 was $0.00, a 100.00% decline year-over-year.
- CNBX PHARMACEUTICALS INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2020-02-29 was $0.00, a 100.00% decline year-over-year.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month as first filed | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month as first filed | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month as first filed |
|---|---|---|---|---|---|---|
| 2021-05-31 | $0.00 10-Q · filed 2021-07-14 | $195.97K derived: sum of 2 quarters · filed 2021-07-14 | $195.97K 10-Q · filed 2021-07-14 | |||
| 2021-02-28 | $195.97K 10-Q · filed 2021-04-14 | $195.97K 10-Q · filed 2021-04-14 | ||||
| 2020-05-31 | $0.00 10-Q · filed 2021-07-14 | $2.67M 10-Q · filed 2020-07-14 | $0.00 derived: sum of 2 quarters · filed 2021-07-14 | $0.00 10-Q · filed 2021-07-14 | -$172.63K 10-Q · filed 2020-07-14 | |
| 2020-02-29 | $0.00 10-Q · filed 2021-04-14 | -$2.10M 10-Q · filed 2020-04-13 | $0.00 10-Q · filed 2021-04-14 | -$2.84M 10-Q · filed 2020-04-13 | ||
| 2019-11-30 | -$740.80K 10-Q · filed 2020-01-14 | |||||
| 2019-05-31 | $987.10K 10-Q · filed 2020-07-14 | $5.87M derived: sum of 2 quarters · filed 2020-07-14 | $5.87M 10-Q · filed 2020-07-14 | |||
| 2019-02-28 | $4.88M 10-Q · filed 2020-04-13 | $4.88M 10-Q · filed 2020-04-13 | ||||
| 2018-11-30 | $0.00 10-Q · filed 2020-01-14 | |||||
| 2018-05-31 | $0.00 10-Q · filed 2019-07-15 | $0.00 10-Q · filed 2019-07-15 |